(Q33604521)

28 July 2017

1 reference

title

Effects of hormonal contraceptives on bone mineral density (English)

1 reference

28 July 2017

B A Cromer

1

1 reference

28 July 2017

publication date

1 March 1999

1 reference

28 July 2017

1 reference

28 July 2017

volume

20

1 reference

28 July 2017

issue

3

1 reference

28 July 2017

page(s)

213-222

1 reference

Effects of hormonal status on bone density in adolescent girls

28 July 2017

cites work

1 reference

12 December 2020

Oral contraceptive use may protect against low bone mass. Henry Ford Hospital Osteoporosis Cooperative Research Group

1 reference

12 December 2020

Bone mineral density in postmenopausal women as determined by prior oral contraceptive use

1 reference

12 December 2020

Bone mineral density in long-term depot medroxyprogesterone acetate acceptors

1 reference

12 December 2020

Longitudinal monitoring of bone mass accumulation in healthy adolescents: evidence for a marked reduction after 16 years of age at the levels of lumbar spine and femoral neck in female subjects

1 reference

12 December 2020

Bone density in premenopausal women: effects of age, dietary intake, physical activity, smoking, and birth-control pills

1 reference

12 December 2020

Depot medroxyprogesterone acetate and osteoporosis. Monitor serum oestradiol concentration in users

1 reference

12 December 2020

Effect of progestin therapy on cortical and trabecular bone: Comparison with estrogen

1 reference

12 December 2020

Recovery of bone density in women who stop using medroxyprogesterone acetate

1 reference

12 December 2020

Associations of parity, breast-feeding, and birth control pills with lumbar spine and femoral neck bone densities

1 reference

12 December 2020

Bone mineral: effects of oral contraceptives, pregnancy, and lactation

1 reference

12 December 2020

Peak bone mass in young women

1 reference

12 December 2020

Timing of peak bone mass in Caucasian females and its implication for the prevention of osteoporosis. Inference from a cross-sectional model

1 reference

12 December 2020

Effective therapy of glucocorticoid-induced osteoporosis with medroxyprogesterone acetate

1 reference

12 December 2020

Oral progestogen-only contraception may protect against loss of bone mass in breast-feeding women

1 reference

12 December 2020

Differential effects on bone density of progestogen-only methods for contraception in premenopausal women

1 reference

12 December 2020

Bone gain in young adult women

1 reference

12 December 2020

Bone loss, contraception and lactation

1 reference

12 December 2020

Osteoporosis: a "new morbidity" for dieting female adolescents?

1 reference

12 December 2020

The effect of oral contraceptive use on vertebral bone mass in pre- and post-menopausal women

1 reference

12 December 2020

Long-term oral contraceptive use does not affect trabecular bone density

1 reference

12 December 2020

Bone density in women receiving depot medroxyprogesterone acetate for contraception

1 reference

12 December 2020

Consensus conference: Osteoporosis

1 reference

12 December 2020

Ovarian endocrine function through five years of continuous treatment with NORPLANT subdermal contraceptive implants

1 reference

12 December 2020

Bone mineralization, hypothalamic amenorrhea, and sex steroid therapy in female adolescents and young adults

1 reference

12 December 2020

A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), or oral contraceptives

1 reference

12 December 2020

Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women

1 reference

12 December 2020

Effects of progestins on bone metabolism in postmenopausal women

1 reference

12 December 2020

Bone mineral density during long-term treatment with Norplant implants and depot medroxyprogesterone acetate. A cross-sectional study of Thai women

1 reference

12 December 2020

Hormone replacement therapy in perimenopausal women with a triphasic contraceptive compound: a three-year prospective study.

1 reference

12 December 2020

10.2165/00002018-199920030-00002

Identifiers

DOI

1 reference

Dimensions Publication ID

28 July 2017

1015965251

0 references

1 reference